CD34 and Kaposi's sarcoma: Given the above, the first objective of this study on KS skin lesions is to assess whether delimiting CD34+SCs/TCs, located in the outer layer of pre-existing blood vessels and around skin appendages, are mesenchymal/stromal cells with a capacity for transdifferentiation into neovessel ECs that express markers for both blood and lymphatic vessels.